Complete response of merkel cell carcinoma with brain metastases to pembrolizumab and radiotherapy: A case report
<p>Merkel cell carcinoma is a rare, but highly malignant and fast growing skin-cancer with high recurrence-rates, deriving from endothelial and neuroendocrine tissues. For advanced Merkel cell carcinoma prognosis is poor [1] and even under cytotoxic chemotherapy there is only a median progress...
Saved in:
Main Authors: | Ansgar Koechel (Author), Franz-Joachim Hilke (Author), Bernhard Klumpp (Author), Christopher Schroeder (Author), Thomas Eigentler (Author), Diana Lomberg (Author), Claus Garbe (Author), Ulrike Leiter (Author) |
---|---|
Format: | Book |
Published: |
Global Journal of Medical and Clinical Case Reports - Peertechz Publications,
2021-06-03.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Coincident Metastatic Melanoma and Merkel Cell Carcinoma with Complete Remission on Treatment with Pembrolizumab
by: Alexander Thiem, et al.
Published: (2017) -
Real-world Treatment Patterns and Outcomes with Systemic Therapies in Unresectable Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma in Germany
by: Felix Kramb, et al.
Published: (2022) -
Advanced Merkel cell carcinoma in setting of pembrolizumab therapy for squamous cell carcinoma
by: Henry Jeon, BSc, et al.
Published: (2024) -
Pembrolizumab-induced lichen planus pemphigoides in a patient with metastatic Merkel cell carcinoma
by: Chase W. Kwon, MD, et al.
Published: (2020) -
Pembrolizumab and palliative radiotherapy in 2 cases of refractory mycosis fungoides
by: Christina J. Walker, MD, et al.
Published: (2021)